Skip to main content
OpenTrials

Clinical trial condition

Meningococcal Infections

Explore clinical trials studying Meningococcal Infections. Study availability and eligibility vary by location and protocol.

217 public trials 6 recruiting studies
Refine in advanced search Browse all conditions

Meningococcal Infections trial results

Completed

The Long-term Antibody Persistence of GSK Biologicals' Meningococcal Vaccine GSK134612 in Healthy Adolescents/Adults

NCT00715910

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +4 more
Locations
  • GSK Investigational Site Daly City, California, United States
  • GSK Investigational Site Fairfield, California, United States
  • GSK Investigational Site Redwood City, California, United States
  • GSK Investigational Site Sacramento, California, United States
View Trial Details
Completed

Safety, Tolerability and Immunogenicity of a Third Dose of One of Four Different Formulations of rMenB + MenACWY Combination Vaccine in Adolescents Who Previously Received the Same Study Vaccines

NCT01367158

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, +13 more
Locations
  • CESFAM Gabriela Mistral: Aurora de Chile 9872 - San Ramón, Saniago, Chile
  • Pontificia Universidad Catolica de Chile Marcoleta 350, Santiago Metropolitan, Chile
  • CAFAM Avenida Carrera 68# 90-88 Piso 4, Bogota D.C., Colombia
  • Centro de Investigacion CafeSalud Medicina Prepagada Carrera 14 No. 94-49 PisoSexto, Bogota D.C., Colombia
View Trial Details
Completed

Extension Study Evaluating Antibody Persistence and Safety, Tolerability and Immunogenicity of a Booster Dose of Novartis rMenB±OMV NZ Vaccine in Healthy UK Children Who Previously Received Three Doses of the Same Vaccine

NCT01026974

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +4 more
Locations
  • Oxford Vaccine Group, Center for Clinical Vaccinology and Tropical Medicine, Churchill Hospital Oxford, United Kingdom
View Trial Details
Completed

Persistence of Immunogenicity of MenACWY Conjugate Vaccine 5 Years After Childhood Vaccination, and Immune Response to a Booster Dose

NCT01823536

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +7 more
Locations
  • 82 Children s Inv Research Prgm (ChIRP) 2900 Medical Center Parkway, Ste. 300 Bentonville, Arkansas, United States
  • 83 AR Pediatric Clinical Research 500 South University, Ste. 200 Little Rock, Arkansas, United States
  • 32 Prem Health Research Center 9317 Firestone Blvd. Downey, California, United States
  • 27 KY Pediatric Adult Research 201 South 5th Street, Suite 102 Bardstown, Kentucky, United States
View all 16 locations
View Trial Details

Related conditions